Who invested in Asklepios BioPharmaceutical?
One investor is on record as having backed Asklepios BioPharmaceutical — Developing next-generation TCR therapies targeting neoantigens in solid cancers, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
askbio.comAsklepios BioPharmaceutical investors
No round dates are on record for Asklepios BioPharmaceutical. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Asklepios BioPharmaceutical are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.